NAME Dr Daniel Speidel
CANCER TYPE General
INSTITUTION Children’s Medical Research Institute
STATE New South Wales
GRANT TYPE $80,000
PROJECT TYPE Research
Clarifying potentially dangerous side effects of Serdematan, a novel anti-cancer drug:
This project will clarify whether use of Serdemetan – a novel anti-cancer drug that has been tested in clinical trials – can make cancer cells multi-drug resistant and basically untreatable. This possibility has been raised by our preliminary data. If true, Serdemetan is associated with an unrecognised but severe risk for patients.